Skip to content

Long Term Effects of Heat and Moisture Exchangers (HMEs)

Long Term Effects of Heat and Moisture Exchangers (HMEs) (Provox® Life™) on Pulmonary Symptoms in Laryngectomized Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06084611
Enrollment
80
Registered
2023-10-16
Start date
2024-03-26
Completion date
2025-09-30
Last updated
2025-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngectomy; Status

Keywords

Laryngectomy, Heat and Moisture Exchanger, HME, Pulmonary rehabilitation

Brief summary

Assessment of long term effect of Provox Life HME use on pulmonary symptoms in laryngectomized patients.

Interventions

Compliant use of Provox Life HMEs

Sponsors

Instituto de Cancer Dr Arnaldo
CollaboratorUNKNOWN
Atos Medical AB
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized Controlled Trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Total laryngectomy, irrespective of pharynx reconstruction method * 18 years or older * Longer than 3 months after total laryngectomy * Longer than 6 weeks after postoperative radiotherapy

Exclusion criteria

* Current use of HMEs (within last 3 months) * Medical problems prohibiting the use of HME * Active recurrent or metastatic disease (medical deterioration) * Recent pulmonary infections/unstable pulmonary condition * Insufficient physical, cognitive, or mental ability required to attach, remove or operate the devices themselves * Low tidal volumes * Unable to understand the Participant Information and/or unable to give Informed Consent

Design outcomes

Primary

MeasureTime frameDescription
CASA-Q ScoreBaseline, 3 months, 6 months, 9 monthsassessed with validated Coughing and Sputum Assessment Questionnaire (CASA-Q). Score between 0 and 100, with higher scores meaning less symptoms and less impact.

Secondary

MeasureTime frameDescription
Forced ExpectorationBaseline, 3 months, 6 months, 9 monthsPatient reported, recorded by tally sheeting
Quality of Life by EQ-5D-5LBaseline, 3 months, 6 months, 9 monthspatient reported, the descriptive system assesses health in five dimensions, from which a health state index score is calculated, range from 0 to 1, with higher scores indicating higher health utility
Jenkins sleep evaluation questionnaireBaseline, 3 months, 6 months, 9 monthsPatient reported to assess sleep quality. Score between 0 and 20, with higher score the more sleep disturbances
Number of involuntary coughs per 24 hoursBaseline, 3 months, 6 months, 9 monthsPatient reported, recorded by tally sheeting
Voice handicap IndexBaseline, 3 months, 6 months, 9 monthspatient reported outcome, score from 0-40, with higher scores indicating greater voice-related handicap.
Consumption of medical devices (Number of devices used)Baseline, 3 months, 6 months, 9 monthsNumber of devices used, by use of patient diary recoding number of devices used
Study-specific questionnaire to assess number of complications and medical treatmentsBaseline, 3 months, 6 months, 9 monthsStudy specific questionnaire to record complications and consumption of medications, diagnostics, treatment, medical care, medical transportation, sick leave
Questionnaire to assess Shortness of BreathBaseline, 3 months, 6 months, 9 monthsfrom Ackerstaff et al., 1993

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026